Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by subaru1ion Apr 04, 2024 10:24am
72 Views
Post# 35970249

Cannabinoids have anti-virus capabilities as well as an

Cannabinoids have anti-virus capabilities as well as an effect on endocannabinoid system, not only humans but other mammals as well.   Mr. Bourla of Pfizer, even the emotional climate is starting to change. 

Now that bird flu is spreading among cows, scientists worry where H5N1 will jump next
On March 25, American officials published an urgent announcement: Dairy cows in Texas, Kansas, and New Mexico were falling sick.
 
The cows had low appetites, and produced less milk than normal. Some farms also discovered wild bird carcasses on their grounds. Tests on a cow throat swab and raw milk samples all confirmed an unusual finding: for the first time, cattle were catching a dangerous form of bird flu.

Within days, highly pathogenic avian flu — a type of influenza A known as H5N1 — was identified in at least a dozen herds across six states, from Texas in the south, up to Michigan and Idaho on the Canadian border.
 
Louise Moncla, an avian influenza researcher and assistant professor at the University of Pennsylvania, was stunned. 
 
"The overwhelming feeling that all of us have is that this is mostly just incredibly strange," she said. "To our knowledge, I've never seen a cow be infected with any influenza A viruses."
 
But the curveball wasn't entirely unexpected. And it may be a harbinger of more species-jumps to come, including the rising possibility of H5N1 appearing in pigs — which could offer it a new route to better adapt to infect humans, inching the world closer to a bird flu pandemic.

https://www.msn.com/en-ca/news/canada/now-that-bird-flu-is-spreading-among-cows-scientists-worry-where-h5n1-will-jump-next/ar-BB1l3oXI?ocid=msedgntp&pc=U531&cvid=b1b1ba254bcc40d980543eb16af24364&ei=66
<< Previous
Bullboard Posts
Next >>